◀ Back to CCR7

CCR7 — IFNB1

Text-mined interactions from Literome

Yen et al., J Immunol 2010 : In vivo treatment with IFN-beta results in lower numbers of DCs migrating to the draining lymph node following exposure to FITC and in reduced expression of CCR7 and MMP-9 in splenic CD11c ( + ) DCs following LPS administration
Aung et al., J Neuroimmunol 2010 (Multiple Sclerosis) : IFN-beta treatment significantly inhibited TLR9 agonist-specific secretion of chemokines, which are ligands for CCR5 positive Th1 cells ( CCL3, CCL4, and CCL5 ), and impaired TLR9 agonist induced up-regulation of CCR7 and IFN-alpha in MS patients